2025-01-01 2025-12-31 false No description of principal activity Capium Accounts Production 1.1 07890935 2025-01-01 2025-12-31 07890935 bus:FullAccounts 2025-01-01 2025-12-31 07890935 bus:Micro-entities 2025-01-01 2025-12-31 07890935 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 07890935 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 07890935 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 07890935 2025-01-01 2025-12-31 07890935 2025-12-31 07890935 bus:RegisteredOffice 2025-01-01 2025-12-31 07890935 core:WithinOneYear 2025-12-31 07890935 core:AfterOneYear 2025-12-31 07890935 1 2025-01-01 2025-12-31 07890935 bus:Director1 2025-01-01 2025-12-31 07890935 bus:Director1 2025-12-31 07890935 bus:Director1 2024-01-01 2024-12-31 07890935 2024-01-01 07890935 bus:LeadAgentIfApplicable 2025-01-01 2025-12-31 07890935 2024-01-01 2024-12-31 07890935 2024-12-31 07890935 core:WithinOneYear 2024-12-31 07890935 core:AfterOneYear 2024-12-31 07890935 bus:EntityAccountantsOrAuditors 2024-01-01 2024-12-31 07890935 core:PlantMachinery 2025-01-01 2025-12-31 07890935 core:PlantMachinery 2025-12-31 07890935 core:PlantMachinery 2024-12-31 07890935 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-12-31 07890935 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 07890935 core:CostValuation core:Non-currentFinancialInstruments 2025-12-31 07890935 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 07890935 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-12-31 07890935 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 07890935 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 07890935 core:Non-currentFinancialInstruments 2025-12-31 07890935 core:Non-currentFinancialInstruments 2024-12-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 07890935
England and Wales
ZIGMA MEDICAL LTD
Unaudited Financial Statements
Period of accounts Start date: 01 January 2025 End date: 31 December 2025

ZIGMA MEDICAL LTD Statement of Financial Position As at 31 December 2025
|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Fixed assets |  |  | 212,262 |  |  | 212,263
Current assets |  | 23,671 |  |  | 36,892 |
Creditors: amount falling due within one year |  | (161,717) |  |  | (127,058) |
Net current assets |  |  | (138,046) |  |  | (90,166)
Total assets less current liabilities |  |  | 74,216 |  |  | 122,097
Creditors: amount falling due after more than one year |  |  | 0 |  |  | (24,131)
Net assets |  |  | 74,216 |  |  | 97,966
Capital and reserves |  |  | 74,216 |  |  | 97,966
NOTES TO THE ACCOUNTS General Information ZIGMA MEDICAL LTD is a private company, limited by shares, registered in England and Wales, registration number 07890935, registration address Flat 3, Advertiser Court, 2 Telegraph Avenue, London, NW9 4BL. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention. The financial statements are prepared in sterling which is the functional currency of the company.
2. | Average number of employees Average number of employees during the year was 2 (2024 : 2).
For the year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's Responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 06 January 2026 and were signed by:
-------------------------------- Vishal SAHNI Director
1